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Genome-wide burden and 
association analyses implicate copy 
number variations in asthma risk 
among children and young adults 
from Latin America
Pablo Oliveira1,2, Gustavo N. O. Costa  1,2, Andresa K. A. Damasceno1,2, Fernando P. Hartwig  3,4,  
George C. G. Barbosa2,5, Camila A. Figueiredo6, Rita de C. Ribeiro-Silva7, Alexandre Pereira8, 
M. Fernanda Lima-Costa9, Fernanda S. Kehdy10, Eduardo Tarazona-Santos11,  
Bernardo L. Horta  3, Laura C. Rodrigues12, Rosemeire L. Fiaccone5 & Maurício L. Barreto  1,2
The genetic architecture of asthma was relatively well explored. However, some work remains in the 
field to improve our understanding on asthma genetics, especially in non-Caucasian populations and 
with regards to commonly neglected genetic variants, such as Copy Number Variations (CNVs). In 
the present study, we investigated the contribution of CNVs on asthma risk among Latin Americans. 
CNVs were inferred from SNP genotyping data. Genome wide burden and association analyses were 
conducted to evaluate the impact of CNVs on asthma outcome. We found no significant difference in 
the numbers of CNVs between asthmatics and non-asthmatics. Nevertheless, we found that CNVs are 
larger in patients then in healthy controls and that CNVs from cases intersect significantly more genes 
and regulatory elements. We also found that a deletion at 6p22.1 is associated with asthma symptoms 
in children from Salvador (Brazil) and in young adults from Pelotas (Brazil). To support our results, 
we conducted an in silico functional analysis and found that this deletion spans several regulatory 
elements, including two promoter elements active in lung cells. In conclusion, we found robust evidence 
that CNVs could contribute for asthma susceptibility. These results uncover a new perspective on the 
influence of genetic factors modulating asthma risk.
Asthma is a chronic inflammatory disorder of the airways characterized by reversible airflow obstruction. Asthma 
is clinically heterogeneous and patients may experience intermittent cough, dyspnea, wheezing, and chest tight-
ness1. The pathophysiology of asthma is complex and typically involves airway eosinophilic inflammation, but 
many individuals can present a persistent noneosinophilic disease2,3. It is estimated that nearly 334 million people 
have asthma worldwide and its prevalence has been increasing in several regions of the planet4,5. In Latin America, 
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the global prevalence of asthma symptoms in adolescents was estimated in approximately 16%6. Markedly, Brazil 
has one of the highest disease prevalence among Latin American countries, reaching 24,4% in 20027,8.
The asthma epidemic observed in the last decades has been essentially attributed to temporal changes in a 
set of different factors, among them diet, allergen exposure, microbiota diversity and occurrence of infections 
that occurred particularly in high income countries and in urban areas of low-to-middle income countries9–12. 
Nevertheless, it is important to note that such changes in social and environmental conditions operate on 
individuals or populations with variable degrees of genetic predisposition to asthma. The initial studies map-
ping candidate genes in the context of asthma identified more than 200 genetic variants associated with dis-
ease development and severity, many of these associations being replicated in different populations13,14. Later, 
several large-scale studies, applying mainly small nucleotide polymorphism (SNP) microarrays and whole 
genome sequencing, have identified multiple short variants (rare and common) associated with asthma in dif-
ferent loci, including: 1q31.3 (DENND1B), 2q12.1 (IL1RL1/IL18R1), 5q12.1 (PDE4D), 5q22.1 (TSLP/WDR36), 
5q31.1 (IL13), 6p21.32 (HLA-DR/DQ), 9p24.1 (IL33), 14q11.2 (DAD1/OXAL1L), 15q22.2 (FOXB1) and 17q21.1 
(ORMDL3/GSDMB)15–20.
Due to all these efforts, the genetic architecture of asthma is now relatively well known, with the genetic factors 
identified so far explaining a reasonable proportion of the heritability attributed to the disease (varying between 
35% and 95%)21. However, some work remains in the field to improve our understanding on asthma genetics, 
especially in non-Caucasian populations and with regards to other variants found in the human genome, such 
as Copy Number Variations (CNVs). CNVs are large deletions or duplications that can encompass genes (and 
their regulatory elements) leading to dosage imbalances22. Estimates suggest that CNVs affect approximately 12% 
of the human genome23. These structural variations have been widely studied in several complex human traits, 
including immunological disorders such as type 1 Diabetes24,25 and rheumatoid arthritis24,26. However, few com-
prehensive studies explored the role of CNVs in asthma and only suggestive associations have been found27,28. 
Additionally, it was observed that genes involved in asthma pathogenesis are affected by CNVs29.
Here, we conducted a genome wide copy number variation study based in our previously published SNP gen-
otyping data19 to investigate the contribution of CNVs on asthma risk in Latin American admixed populations.
Results
Global contribution of copy number variations on asthma outcome. Copy number variations in 
the genome of admixed children from Salvador (Northeast Region of Brazil) (Table 1) were inferred from SNP 
genotyping data (Illumina HumanOmni 2.5–8v1 panel) using two distinct algorithms implemented in PennCNV 
and QuantiSNP. To combine CNVs corresponding to the same event, deletions or duplications showing sequence 
overlap were grouped into a single copy number variation region (CNVR). Only CNVRs detected by both pro-
grams were considered valid. After stringent quality control (detailed in Methods), a set of 3,698 CNVRs (3,169 
deletions and 529 duplications) was identified in 872 individuals (Fig. 1A). Of these, only 114 deletions and 31 
duplications presented frequencies ≥ 1% in this study population (Fig. 1B and Supplementary Table 1). Regarding 
the median size of the CNVRs, it was found that duplications (22.0 kb) are more than twice as large as deletions 
(9.6 kb) (Fig. 1C). Finally, we found that CNVRs were well dispersed across the genome and the distribution of 
these events reflects the size of the human chromosomes, with decreasing frequency of CNVRs from the first to 
the twenty-second autosomal chromosome (Fig. 1D).
After identifying CNVs in the genome of children from Salvador, analyses were conducted to evaluate the 
global impact of these structural variations on asthma outcome (Table 2). First, the number of CNVR per indi-
vidual (CNVR count) was compared between patients and healthy controls and no significant difference was 
found. In average, it was observed 12.8 deletions and 3.6 duplications per asthmatic individual, while among 
non-asthmatic subjects we identified similar proportions, 14.3 deletions and 3.0 duplications per sample. Next, 
the size of CNVRs was compared between groups and it was found that structural variations (deletions + dupli-
cations) from asthmatic individuals are significantly larger than those presented by their controls (p = 5 × 10−3). 
The mean sizes of the deletions found in cases and controls were 35.6 kb and 26.4 kb, respectively (p = 0.03). 
Meanwhile, the average sizes of the duplications from cases and controls were 85.1 kb and 62.1 kb, respectively 
(p = 0.05). Based on this finding, we hypothesized that CNVRs from cases could mobilize more genes, regu-
latory and constrained elements than those from controls. To evaluate this assumption, CNVR positions were 
cross-referenced with DNA sequence annotations. As shown in Table 2, we found no significant differences 
regarding the number of constrained elements (sequence conservation across mammals) intersected by deletions 
Sample Characteristics
Salvador, Brazil Pelotas, Brazil
Cases Controls Cases Controls
Number of individuals 188 684 367 1381
Sex (male/female) 108/80 370/314 165/202 678/703
Median age, years (IQR) 6 (4–11) 6 (4–10) 23 (22–23) 23 (22–23)
LRRSD, mediana 0.155 0.152 0.155 0.151
Ancestry, median %b
EUR AFR NAT EUR AFR NAT EUR AFR NAT EUR AFR NAT
40.4 52.1 5.9 42.3 50.8 5.8 81.4 8.9 7.6 84.1 7.0 7.1
Table 1. Characteristics of the studied samples (after quality control). aLog2 of R ratio standard deviation. 
bAncestry proportions (ADMIXTURE method), EUR: European; AFR: African; NAT: Native American. IQR, 
interquartile range.
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and duplications from asthmatic and non-asthmatic individuals. On the other hand, CNVRs from cases mobi-
lized significantly more genes (deletions, p = 0.01; duplications, p = 0.02; deletions + duplications, p = 2 × 10−4) 
and more regulatory elements (deletions, p = 0.03; duplications, p = 0.06; deletions + duplications, p = 7 × 10−4) 
than those from controls.
Association of copy number variations with asthma in salvador. In the discovery association phase, 
analyses were conducted to evaluate the effect of specific structural variations on asthma risk in children from 
Salvador. The association of CNVRs with asthma was investigated by comparing frequencies of low-to-common 
variations (minor allele frequency ≥1%) between asthmatic and non-asthmatic individuals, under an additive 
model. Sex and age, which are considered classic risk factors for asthma, were included as covariates in the logistic 
regression analysis. Additionally, Log2 of R ratio standard deviation (LRRSD), to account for potential differences 
in sample and/or call quality between cases and controls, and the first three principal components, to correct 
for population stratification, were included in the regression model. This initial screening stage revealed several 
deletions and duplications that were nominally associated with asthma (p ≤ 0.05). Supplementary Table 2 shows 
the results for all CNVRs evaluated in the discovery study. Remarkably, only one deletion with approximately 
41.6 kb of size, located at 6p22.1 (6:29,889,788–29,931,412) (Supplementary Fig. 2A), was significantly associated 
Figure 1. Copy number variation regions (CNVRs) detected in the genome of children from Salvador, Brazil. 
Copy number variations in the genome of 872 individuals from the SCAALA-Salvador cohort were inferred 
from SNP microarray data (Illumina HumanOmni 2.5–8v1 panel), using algorithms implemented in PennCNV 
v1.0.1 and QuantiSNP v2.0. Deletions or duplications showing sequence overlap were grouped into a single 
CNVR. (A) Number (#) of CNVRs detected by PennCNV and QuantiSNP (after quality control). Only CNVRs 
detected by both algorithms were considered for further analysis. (B) Frequency of deletions and duplications 
(<1% or ≥1%) in the study population. (C) Size of the deletions and duplications (bp, base pair), violin plots. 
(D) Number (#) of CNVRs by human autosomal chromosome.
www.nature.com/scientificreports/
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with the disease (OR = 3.0, p = 2 × 10−4) (Table 3), overcoming the significance level established for this discovery 
phase (p ≤ 3.4 × 10−4).
Replication study and association in different ancestry compositions. We then attempted to repli-
cate the association signal at 6p22.1 in another admixed Brazilian sample, composed of 1,748 young adults from 
the city of Pelotas, located in the Southern Region of Brazil (Table 1). CNVRs located in the locus 6p22.1 were 
also inferred from SNP genotyping data (Illumina HumanOmni 2.5–8v1 panel) using PennCNV and QuantiSNP. 
Interestingly, both algorithms detected a 49.6 kb deletion (6:29,881,842–29,931,412) (Supplementary Fig. 2B) 
whose limits overlap those of the deletion associated with asthma in Salvador, representing, therefore, a single 
CNVR. As show in Table 3, the association of this structural variation with asthma was replicated in this second 
Brazilian cohort (OR = 1.9, p = 4 × 10−3), with p value below the significance threshold assumed for the replica-
tion phase (p = 0.05).
Deletions
Asthmatics Non-asthmatics
Ratio pMean SD Median P25 P75 Mean SD Median P25 P75
CNVR counta 12.8 11.2 10.5 8.0 14.0 14.3 18.0 10.0 8.0 14.0 0.9 0.8
Size (kb)b 35.6 94.3 11.3 5.1 28.2 26.4 63.2 9.9 5.0 24.3 1.3 0.03
Gene countc 1.1 2.0 1.0 0.0 2.0 0.8 1.6 1.0 0.0 1.0 1.4 0.01
Regulatory 
element countd 5.1 11.6 2.0 0.0 5.0 3.9 8.7 2.0 0.0 4.0 1.3 0.03
GERP element 
counte 6.1 8.1 3.9 0.5 8.0 6.5 8.6 4.2 0.7 8.7 0.9 0.1
Duplications
CNVR counta 3.6 4.5 2.0 1.0 4.0 3.0 3.7 2.0 1.0 4.0 1.2 0.2
Size (kb)b 85.1 161.2 28.1 13.6 75.8 62.1 118.3 22.9 11.2 53.1 1.4 0.05
Gene countc 2.8 4.2 1.0 0.0 3.0 2.1 3.5 1.0 0.0 2.0 1.3 0.02
Regulatory 
element countd 14.0 22.4 5.0 2.0 15.0 11.4 19.7 4.0 1.0 12.0 1.2 0.06
GERP element 
counte 7.5 8.9 4.7 2.1 9.7 7.6 8.2 4.9 2.4 10.2 1.0 0.5
Deletions + Duplications
CNVR counta 16.4 12.4 13.0 10.0 18.0 17.3 18.4 13.0 10.0 18.0 1.0 0.5
Size (kb)b 43.0 108.4 13.0 5.8 32.9 31.6 74.8 11.4 5.5 28.9 1.4 5 × 10−3
Gene countc 1.4 2.7 1.0 0.0 2.0 1.0 2.1 1.0 0.0 1.0 1.4 2 × 10−4
Regulatory 
element countd 6.8 14.8 2.0 0.0 7.0 5.0 11.5 2.0 0.0 5.0 1.4 7 × 10
−4
GERP element 
counte 6.3 8.3 4.0 0.7 8.3 6.6 8.5 4.3 1.0 8.9 1.0 0.1
Table 2. Global contribution of copy number variation regions (CNVRs) on asthma outcome. Asthmatic and 
non-asthmatic children from Salvador-SCAALA were compared in terms of: acount of CNVRs per individual; 
bestimated size of CNVRs (kb, kilobase); cnumber of genes captured by CNVR; dnumber of regulatory elements 
captured by CNVR; enumber of GERP constrained elements captured by CNVR. SD: standard deviation; P25: 
25% percentile; P75: 75% percentile; Ratio: case/ctrl ratio (mean); p values ≤ 0.05 were considered statistically 
significant [Mann-Whitney U test (two-sided)].
CNVR
CNVR 
class
CNVR 
size (bp)
Freq. 
Case
Freq. 
Ctrl OR 95% CI p Power
Salvador, Brazil (Discovery)
6:29,889,788–29,931,412 Deletion 41,624 6.6 2.4 3.0 1.7–5.2 2 × 10−4 0.902
Pelotas, Brazil (Replication)
6:29,881,842–29,931,412 Deletion 49,570 4.0 1.6 1.9 1.2–2.8 4 × 10−3 0.837
Random-effects meta-analysis
OR p
2.3 3 × 10−6
Table 3. A deletion region located in the locus 6p22.1 is associated with asthma in two independent Brazilian 
populations. CNVR: Copy number variation region, chromosome:start-end; bp: base pair; Frequency of CNVR 
(%); Case: asthmatic; Ctrl: non-asthmatic; OR, odds ratio; SE, SE of odds ratio (OR); 95% CI, 95% confidence 
interval; p, p value (additive model). The significance threshold established for the discovery phase was 
p ≤ 3.4 × 10−4; The significance level applied in the replication study was p = 0.05; Power: A posteriori statistical 
power. Covariates in multivariate analysis: sex, age, Log2 of R ratio standard deviation (LRRSD) and principal 
components (PC1, PC2 and PC3). Human genome assembly: GRCh38.
www.nature.com/scientificreports/
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Next, we conducted a meta-analysis on Salvador and Pelotas samples, by applying a random-effects model that 
assumes significant inter-study variability (Table 3). This analysis confirmed association of this deletion with the 
disease (OR = 2.3; p = 3 × 10−6), providing support for the notion that structural variations could represent risk 
factors for asthma.
Additional experiments were conducted to evaluate the effect of the deletion at 6p22.1 in subjects with dif-
ferent ancestry. First, our data sets were dichotomized in groups of individuals with proportion of European 
ancestry above or below the median. Next, we carried out association tests in these subgroups and, despite the 
reduced sample sizes, the deletion was nominally associated (p ≤ 0.05) with asthma in both situations (proportion 
of European ancestry above or below the median) (Supplementary Table 3).
Fine-mapping of the 6p22.1 region. Considering that 6p22.1 is a very complex region, making associ-
ation signals difficult to interpret, we performed a fine-mapping of the entire locus (6:27,100,000–30,500,000; 
RefSeq: GRCh38). We focused in the identification of SNPs that could explain the association signal found in 
this region (Supplementary Fig. 3). Notably, no robust linkage disequilibrium (r2 > 0.6) was found between our 
deletion and any evaluated SNP in the region. In addition, none of the SNPs investigated in this region was signif-
icantly associated with asthma risk in Salvador [locus p-value threshold = 8 × 10−6 (0.05/6057 SNPs)] and Pelotas 
[locus p-value threshold = 9 × 10−6 (0.05/5782 SNPs)]. We also carried out conditional tests to evaluate the possi-
bility that our deletion and any other SNP tested could be capturing the same association signal. Remarkably, we 
found that association signals for the SNPs at 6p22.1 are not influenced by the signal of the reported deletion, i.e., 
the −log10 (p values) after adjustment for the deletion genotypes were strongly correlated with −log10 (p values) 
without adjustment [Pearson correlation: Salvador (r2 = 0.97; p-value < 10−4); Pelotas (r2 = 0.98; p-value < 10−4)].
In silico functional analyses. To investigate the regulatory potential of the deletion at 6p22.1, the region 
was cross-referenced with genomic and epigenomic annotations, obtained from the Ensembl database. This 
region was evaluated in terms of transcripts location, binding sites for transcription factors, sequence constraint, 
chromatin segmentation state (evidences of promoter and enhancer marks) and enrichment for marks of open 
chromatin (DNase I hypersensitive sites). In Fig. 2, it is possible to observe the limits found in Salvador and 
Pelotas for the asthma-associated deletion. This deletion region may have relevant functional consequences, 
since it covers a region with seven transcripts, numerous constrained sequences and several regulatory elements 
(including promoter and promoter flanking regions, transcription factor binding sites and an open chromatin 
element). In addition, it is close to HLA genes (HLA-G and HLA-A) and intersects a SNP (rs2523809) previously 
associated with dysregulation of plasma IgE concentrations in Europeans30. Collectively, these data support the 
biological plausibility of our findings.
Figure 2. In silico functional study on the regulatory potential of the deletion at 6p22.1. Schematic representation 
of the locus containing the deletion region associated with asthma in Brazilian populations (expanded view: 
6:29,801,381–30,018,756; RefSeq: GRCh38). This region was cross-referenced with DNA sequence annotations, 
including: location of protein coding or non-protein coding genes (GENCODE 26); presence of large structural 
variations identified by the 1000 genomes project, phase 3 (SV – 1KG 3); position of putative regulatory elements 
(regulatory build); location of constrained elements for 40 eutherian mammals (GERP, Genomic Evolutionary 
Rate Profiling); presence of SNPs and short indels associated with any human phenotype in previous studies. 
Limits of the deletions found in samples from Salvador or Pelotas are symbolized by a yellow or a green bar, 
respectively. Image created using the Ensembl genome browser (http://www.ensembl.org).
www.nature.com/scientificreports/
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Discussion
Initially, we conducted an exploratory analysis, based in our previously published high-density SNP genotyping 
data19, to detect copy number variations throughout the genome of children from Salvador, Brazil. After stringent 
quality control, the algorithm implemented in PennCNV identified 7,155 deletions and 4,041 duplications, while 
QuantiSNP detected 11,985 deletions and 10,843 duplications, in 872 individuals. To avoid false discoveries, we 
focused only on the variations simultaneously detected by the two programs, remaining 3,169 deletions and 529 
duplications. These results highlight an imbalanced ratio between the numbers of deletions and duplications. 
This can be explained primarily by limitations related to the PennCNV algorithm for the detection of duplication 
events, which are normally inferred by increased number of peaks in the BAF distribution, as well as increased 
LRR values. Wang and colleagues (2007)31 obtained similar results when testing the PennCNV package. In their 
data set, deletions were approximately twofold more frequent than duplications. Furthermore, they also found 
that deletions presented smaller sizes than duplications.
Then, we tested the hypothesis that the cumulative effect of multiple structural variations through an individ-
ual’s genome could increase asthma risk. Initially, we found no significant difference in the numbers of CNVRs 
between asthmatic and non-asthmatic individuals. Nevertheless, we found that CNVRs were larger in cases when 
compared to controls and that CNVRs from cases intersected significantly more genes and regulatory elements. 
Despite the modest differences found, this may be increasing the risk of presenting asthma symptoms. To date, the 
only genome-wide burden analysis associating asthma and CNVs found no evidences on the global contribution 
of these variations in disease risk27. However, it is important to note that this cited study was carried out among 
Australian children (European descent), using a less dense SNP chip (Illumina 610 K array). Besides that, their 
analyses were restricted to large (100 to 1.000 kb) and common CNVs [minor allele frequency (MAF) >5%]. In 
the present study, more robust conditions were created to detect the joint effect of structural variations on asthma 
risk by applying a much higher density SNP platform (with 2,237,482 SNPs) and by using broader spectra of CNV 
size (ranging from 1 to 1,430 kb) and frequency (rare to common). Similar results have already been described for 
other human traits, such as schizophrenia32 and obesity33.
Individual effects of CNVRs were also evaluated and we found that a deletion located at 6p22.1 was signifi-
cantly associated with asthma symptoms in Salvador. The SCAALA-Salvador cohort has the largest proportion of 
African ancestry (50.8%) among the EPIGEN-Brazil populations34, with 42.9% and 6.4% of European and Native 
American ancestries, respectively. This association was replicated in another Brazilian admixed population from 
the EPIGEN-Brazil program, composed of young adults from the city of Pelotas. Global ancestry in Pelotas is 
76.1% European, 15.9% African, and 8% Native American. Even though genetic ancestry at locus-segment level 
needs to be investigated, this consistent effect found in populations with different genetic backgrounds suggests 
functional relevance for this deletion or strong linkage to a causal variant yet to be identified.
Despite our sample size in the discovery study (188 asthma cases and 684 controls), our analysis was well pow-
ered (>80%) to detect the effect found for the deletion at 6p22.1 (OR = 3.0). This was possible because we evalu-
ated only 145 low-to-common (MAF ≥ 1%) CNVRs that placed the significance level at 3.4 × 10−4. Even though 
not achieving statistical significance following adjustment for multiple tests, several other CNVRs were nominally 
associated (p ≤ 0.05) with asthma symptoms in the discovery phase (Supplementary Table 2). Although further 
studies using larger samples are necessary to confirm these results, we investigated if these nominal associations 
occurred in loci associated with asthma symptoms in our previous study19. Notably, no CNVRs were identi-
fied in the regions 14q11.2 (DAD1/OXAL1L genes) and 15q22.2 (FOXB1 gene) that could explain SNP associa-
tions. Furthermore, we found no deletions or duplications nominally associated with asthma symptoms in loci 
consistently associated with the disease in previous studies, including: DENND1B, IL1RL1, PDE4D, TSLP, IL13, 
HLA-DR/DQ and IL33 regions.
To support our results, we carried out an in silico functional analysis of the deletion at 6p22.1. Remarkably, 
this structural variation region was previously identified through DNA sequencing in populations from several 
continents by the 1000 genomes project, phase 3 (Del 6:29,882,895–29,937,238, RefSeq: GRCh38; DGVa ID: 
esv3608493). We evaluated several genomic annotations in this region and found that the sequence covered by 
the asthma-associated deletion spans essentially pseudogenes. Nevertheless, it deletes several regulatory elements 
in this region, including two promoters active in lung cells (empirical data from the ENCODE project)35 that 
could be involved in local gene expression regulation. Indeed, this deletion is located near the HLA-A and HLA-G 
genes and could impact on their transcriptional regulations. The HLA-A product, as a classical MHC I antigen, is 
responsible for initiating cell-mediated immunity36. On the other hand, HLA-G protein, a non-classical MHC I 
antigen, has immunoinhibitory functions and the loss of HLA-G immune-mediated control seems to be involved 
in the onset of inflammatory diseases37. Interestingly, Granada and colleagues (2012)30 found several SNPs near 
the HLA-A and HLA-G genes as potential determinants of atopy and IgE production among Europeans. In the 
aforementioned study, the SNP rs2523809, which is located at approximately 59 kb 5′ of the HLA-A gene and is 
intersected by our asthma-associated deletion, was strongly associated (4 × 10−8) with dysregulation of plasma 
IgE concentrations. Linkage disequilibrium between the SNP rs2523809 and the deletion at 6p22.1 was inves-
tigated in our cohorts and very low values were found (r2 < 0.1). Additionally, a recent meta-analysis identified 
another SNP (rs1233578) in the region 6p22.1 that was strongly associated with asthma risk in individuals from 
ethnically diverse populations38. This SNP is located more than 1 Mb away from the 5′ end of the CNV reported in 
our study and they are not in linkage disequilibrium in our cohorts (r2 < 0.2). In addition, the association of this 
SNP with asthma was not replicated in Salvador (p-value = 0.38) and in Pelotas (p-value = 0.42).
Another important aspect is that we identified a genetic variant that confers susceptibility to asthma in popu-
lations with very different ages: children from Salvador (4–11 years of age) and young adults from Pelotas (22–23 
years of age). Asthma has various clinical phenotypes that are age-related39 and several evidences indicate that 
although some genetic variations can influence risk of both childhood and adult-onset asthma, other loci are 
exclusively associated to each group18. Although we cannot establish that the appearance of asthma symptoms 
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in patients from Pelotas occurred in adult life, it is possible to affirm that the deletion at 6p22.1 is a genetic risk 
factor for current asthma in both age groups. Furthermore, phenotyping was conducted in the present study by 
using the phase II ISAAC questionnaire on asthma symptoms, a tool that has already been applied in hundreds 
of studies and has proved to be useful to determine asthma prevalence worldwide40. However, we did not distin-
guish atopic from non-atopic asthma. Considering that atopic asthma represents a minor proportion of the cases 
reported in Latin America41 and that the 6p22.1 locus is potentially involved in IgE response30, the associations 
found in our data sets may be underestimated by phenotypic heterogeneity.
In conclusion, we found robust evidence that CNVs could contribute for asthma susceptibility. More spe-
cifically and to the best of our knowledge, for the first time we identified a deletion that confers susceptibility to 
asthma in Latin American children and young adults. These results uncover a new perspective on the influence of 
genetic factors modulating asthma risk.
Methods
Study design and populations. Discovery cohort (Salvador). As previously described34, the SCAALA-
Salvador (Social Changes, Asthma and Allergy in Latin America) is one of the three population-based cohorts 
from the EPIGEN-Brazil initiative on population genomics and genetic epidemiology. Originally, the SCAALA-
Salvador is a longitudinal study that comprises children living in Salvador (Bahia State), a city of approximately 3 
million inhabitants in Northeastern Brazil. Further details on the original cohort and the procedures for collect-
ing data are described by Barreto and colleagues42.
Replication cohort (Pelotas). The replication of the association findings was conducted in a cohort of Brazilians 
from the city of Pelotas, Rio Grande do Sul State. Pelotas is located in the Southern region of Brazil with approx-
imately 340,000 inhabitants. Throughout 1982, the three maternity hospitals in the city were visited daily and 
births were recorded, corresponding to 99.2% of all births in the city. The live-born infants whose families lived 
in the urban area constituted the original cohort. Further details on the Pelotas (1982) birth cohort can be seen 
in Victora and Barros43.
Ethics statement and accordance with guidelines and regulations. The SCAALA-Salvador study 
was approved by the ethics committee of the Institute of Collective Health (ISC) of the Federal University of Bahia 
(UFBA). For the Pelotas project, the Ethical Review Board of the Federal University of Pelotas (UFPel) approved 
all phases of the study. Genotyping of individuals from both cohorts was approved by Brazil’s National Research 
Ethics Committee (CONEP), as part of the EPIGEN-Brazil project (resolution number: 15895). Informed consent 
was obtained from all participants at baseline and at all follow-up interviews. Participants signed an informed 
consent form and authorized their genotyping. All methods and protocols were performed in accordance with the 
principles of the Declaration of Helsinki.
Definition of asthma symptoms. Definition of asthma symptoms and phenotyping were performed in 
the same way for both discovery (Salvador) and replication (Pelotas) studies. Parents or caregivers of children 
from Salvador (resurveyed in 2005, 4–11 years of age) and young adults from Pelotas (resurveyed in 2004, 22–23 
years of age) answered Portuguese-adapted questionnaires from The International Study of Asthma and Allergies 
in Childhood (ISAAC) project40. The interviews were carried out by appropriately trained researchers and indi-
viduals were classified as asthmatic when wheezing was reported in the 12 months prior to the questionnaire 
application and by reporting any one of the following situations: (1) diagnosis of asthma ever; (2) wheezing dur-
ing exercise in the last 12 months; (3) four or more episodes of wheezing in the last 12 months; or (4) waking up at 
night because of wheezing in the last 12 months. All other individuals were classified as current non-asthmatics.
SNP genotyping and quality control. Procedures for SNP genotyping and quality control (QC) were 
extensively described in Kehdy et al.44. Briefly, 1,307 children from Salvador and 1,841 young adults from Pelotas, 
who fully answered the asthma survey, were successfully genotyped as part of the EPIGEN-Brazil project using 
the Illumina HumanOmni 2.5–8v1 BeadChip panel (comprising 2,237,482 autosomal SNPs; Illumina, San Diego, 
CA). Stringent post-genotyping QC procedures and filtering were performed for both populations separately 
and 1 individual from Salvador and 20 from Pelotas were excluded due to inconsistency between the sex reg-
istered and the genetic sex, based on X-chromosome markers (using PLINK v1.945; –check-sex). Fifty seven 
samples from Salvador and 71 from Pelotas were eliminated from further analysis because of close relationship 
estimated by kinship coefficients for each pair of individuals, using a method implemented in the REAP software 
(Relatedness Estimation in Admixed Populations)46. Pairs of individuals were considered closely related if the 
estimated kinship coefficient between them was ≥0.1. Finally, we eliminated 1 individual from Salvador and 2 
from Pelotas presenting more than 1% of undetermined genotypes, using PLINK v1.9 (−mind 0.01). QC was also 
performed to eliminate autosomal SNPs showing significant deviation from the Hardy-Weinberg equilibrium 
[p < 10−3 (−hwe 0.001), based on controls only; 56,496 in Salvador and 82,307 in Pelotas] and SNPs with more 
than 1% of undetermined genotypes (−geno 0.01) in Salvador (112,230) and in Pelotas (99,419). These last two 
QC stages were also carried out using PLINK v1.9.
Copy number variation calling and quality control. Intensity values from autosomal SNP probes that 
passed SNP QC were used to detect genomic structural variations based on algorithms implemented in two of 
the most used programs in the literature for the detection of copy number variations from SNP arrays: PennCNV 
v1.0.131 and QuantiSNP v2.047. Both PennCNV and QuantiSNP evaluate deviations in signal intensity patterns to 
identify changes in number of copies of DNA segments.
Two intensity values were obtained for each probe (using Genome Studio software v2011.1): LRR (Log2 of R 
ratio, where R is the value of the total intensity for the two SNP alleles) and BAF (B allele frequency, a measure 
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of allelic intensity ratio for each SNP). Intensity values were quantile-normalized in order to avoid batch effects. 
SNP arrays may show variations in hybridization intensity. An algorithm described by Diskin and colleagues48 
and implemented in PennCNV (genomic_wave.pl option; -adjust argument) was applied to adjust signal intensity 
values from samples showing a waveness factor (WF value) less than -0.04 or higher than 0.04.
To limit the occurrence of false discoveries in the initial phase, only CNVs ≥ 1 kb and overlapping at least 5 
SNP probes were taken into account49. Considering that telomeric and centromeric regions show excessive spuri-
ous CNV calls31, CNVs with at least 1 bp (base pair) overlap with centromeric or telomeric regions (500 kb+/−) 
were not included in our analyses. Additionally, in MHC region (6:28,510,120–33,480,577, RefSeq: GRCh38), a 
highly repetitive locus, CNV calls with greater than 70% repeat coverage were excluded. RepeatMasker software 
(v4.0.6; default options) was used to screen interspersed repeats and low complexity DNA sequences. Following 
the QC procedures, 235 samples from Salvador were excluded on the basis of large variation in LRR intensities 
at genome-wide level [standard deviation (SD) >0.20]. Also, 141 samples from Salvador were eliminated from 
further analysis due to large number of CNVs called (2 SD from the mean) or large CNV sizes (2 SD from the 
mean). This CNV-based genomic QC was not applied to the Pelotas cohort, since analysis in the replication stage 
was restricted to the 6p22.1 region.
Definition of copy number variation regions (CNVRs). In order to combine structural variations 
corresponding to the same event, the duplications or deletions detected in the genome of the individuals were 
grouped into copy number variation regions (CNVRs). CNVs overlapping at least 1 base-pair were merged into a 
single CNVR50, using CNVRuler software51. To avoid overestimation of CNVR size and frequency, regional den-
sity (recurrence) of participating CNVs were checked and sparse areas not satisfying the density threshold (10%) 
were trimmed. Only CNVRs called by both PennCNV and QuantiSNP were considered valid.
Sequence annotations. The regulatory potential of CNVs associated with asthma was evaluated in silico. 
Comparative genomic data and regulatory features for the region 6:29,881,842–29,931,412 (RefSeq: GRCh38) 
were obtained from the Ensembl database (http://www.ensembl.org). The position of the deletion at 6p22.1 was 
cross-referenced with DNA sequence annotations, including: (1) transcripts location (introns, exons, 3′ and 5′ 
untranslated regions); (2) presence of consensus sequences for transcription factors; (3) genomic evolutionary 
rate profiling–constrained elements for 40 eutherian mammals (GERP)52; (4) chromatin segmentation state35; and 
(5) indicative of chromatin accessibility (DNase I hypersensitive sites)35.
Population structure analyses. To explore the admixed nature of our samples, we conducted principal 
components analysis (PCA) of ancestry, using PLINK v1.9. In Salvador (Supplementary Fig. 1A,B) and Pelotas 
(Supplementary Fig. 1C,D), only the first three principal components (PCs) account each one for more than 2% of 
data variance. So, these three more informative PCs were used to adjust for population stratification in the associ-
ation tests. Additionally, the ADMIXTURE method53 was applied to dissect the ancestry composition of asthma 
cases and controls (Table 1). Based on the results of ADMIXTURE with number of ancestral clusters (K) = 3, we 
were able to differentiate the main continental parental groups that contributed to the formation of the Brazilian 
population: Europeans, Africans and Native Americans. These analyses were previously detailed in Kehdy et al.44.
Statistical analysis. Burden analysis. Burden analyses were conducted to evaluate the global impact of 
CNVs on asthma outcome. Cases and controls from the discovery cohort were compared in terms of: (1) num-
ber of CNVRs per individual (CNVR count); (2) estimated size of CNVRs; (3) number of genes overlapped by a 
CNVR (at least 1 bp overlapped with any genic region); (4) number of regulatory regions overlapped by a CNVR 
(at least 1 bp overlapped with regulatory elements: promoter and promoter flanking region, enhancer, open chro-
matin and transcription factor binding site); and (5) number of constrained elements captured by a CNVR (at 
least 1 bp overlapped with GERP elements). Size of CNVRs and number of genes, regulatory and constrained 
regions covered by CNVRs are related to the total for all CNVRs per individual. Gene, regulatory and constrained 
element annotations were obtained from the Ensembl Biomart tool (http://www.ensembl.org/biomart; Ensembl 
Genes 88, RefSeq: GRCh38). All comparisons were performed with the non-parametric Mann-Whitney U test 
(two-sided), using SPSS statistics software v20.0 (IBM). Significance level used in this analysis was α = 0.05.
Association analysis. CNVRs were defined as low-to-common if their frequencies were ≥1% in our cohorts 
(cases and controls) and only low-to-common variants were evaluated at this point. For the discovery and repli-
cation phases, association of CNVRs with asthma risk was evaluated using PLINK v1.9. Distribution of genomic 
copy number segments was compared between cases and controls under an additive genetic model (0, 1 or 2 allele 
copies for deletions; 2, 3 or 4 allele copies for duplications). No CNVR with 5 or more allele copies has passed 
CNV-based QC. Classical risk factors for asthma, such as sex and age, were included as covariates from the 
logistic regression model. In addition, Log2 of R ratio standard deviation (LRRSD), to account for potential dif-
ferences in sample and/or call quality between cases and controls, and the first three principal components from 
PCA (Supplementary Fig, 1A,C), to correct for eventual population stratification, were included in the regres-
sion model. Results are described as estimates of odds ratio (OR) and confidence interval (CI). In the discovery 
phase, a multiple test threshold (Bonferroni) was applied to the p values to control the probability of observing 
false-positive results. After that, p values ≤ 3.4 × 10−4 (0.05/145) were taken as significant. In the replication study, 
since only one CNVR was tested, the significance level was α = 0.05. To combine the association results found 
in both cohorts, a random-effects meta-analysis (assuming inter-study variability) was carried out using PLINK 
v1.9. A posteriori statistical power was estimated using the GAS Power Calculator tool. Linkage disequilibrium 
calculations (r2) were conducted using PLINK v1.9. Pearson correlations were carried out using SPSS statistics 
software v20.0.
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